Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ridker

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
European Heart Journal|December 1, 2001
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosisG J Blake, C Schmitz, K Lindpaintner, et al.
American Heart Journal|May 29, 2001
The pravastatin inflammation CRP evaluation (PRINCE): rationale and designM A Albert, J Staggers, P Chew, et al.
Thrombosis and Haemostasis|January 31, 2002
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarctionR Y Zee, K Lunze, K Lindpaintner, et al.
Journal of the American College of Cardiology|August 10, 2000
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ A de Lemos, C H Hennekens, P M Ridker
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolismR Y L Zee, H H Hegener, P M Ridker
Circulation|December 22, 1998
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and strokeP M Ridker, C H Hennekens, M J Stampfer, et al.
AJNR. American Journal of Neuroradiology|January 1, 1988
Paraneoplastic cerebellar degeneration in a patient with ovarian carcinomaA M Wang, S Leibowich, P M Ridker, et al.
Annals of Internal Medicine|September 15, 1993
Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1P M Ridker, C O'Donnell, V J Marder, et al.
The New England Journal of Medicine|March 25, 2000
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenP M Ridker, C H Hennekens, J E Buring, et al.
Circulation|November 7, 2001
Soluble CD40L and cardiovascular risk in womenU Schönbeck, N Varo, P Libby, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
European Heart Journal|December 1, 2001
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosisG J Blake, C Schmitz, K Lindpaintner, et al.
American Heart Journal|May 29, 2001
The pravastatin inflammation CRP evaluation (PRINCE): rationale and designM A Albert, J Staggers, P Chew, et al.
Thrombosis and Haemostasis|January 31, 2002
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarctionR Y Zee, K Lunze, K Lindpaintner, et al.
Journal of the American College of Cardiology|August 10, 2000
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ A de Lemos, C H Hennekens, P M Ridker
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolismR Y L Zee, H H Hegener, P M Ridker
Circulation|December 22, 1998
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and strokeP M Ridker, C H Hennekens, M J Stampfer, et al.
AJNR. American Journal of Neuroradiology|January 1, 1988
Paraneoplastic cerebellar degeneration in a patient with ovarian carcinomaA M Wang, S Leibowich, P M Ridker, et al.
Annals of Internal Medicine|September 15, 1993
Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1P M Ridker, C O'Donnell, V J Marder, et al.
The New England Journal of Medicine|March 25, 2000
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenP M Ridker, C H Hennekens, J E Buring, et al.
Circulation|November 7, 2001
Soluble CD40L and cardiovascular risk in womenU Schönbeck, N Varo, P Libby, et al.
Pageof 21